Effect of Malaria on Hematological Profile in Medical Ward of Chandka Medical College Larkana
DOI:
https://doi.org/10.59573/emsj.7(2).2023.23Keywords:
malaria, anemia, thrombocytopenia, hematological profile, rapid acting ICT method, plasmodiumAbstract
Introduction. Malaria is a serious disease transmitted by female anopheles mosquito and caused by Plasmodium that infects red blood cells and affects millions of people globally, leading to many complications and deaths. The complete blood picture (CBC), which measures the different components of blood, is altered by the disease. Hemoglobin is responsible for carrying oxygen and is affected by malaria, resulting in a decrease in hemoglobin, causing anemia. White blood cells, which help fight off infections, initially increase in number during malaria, but decrease as the disease progresses, indicating a weakened immune response. Platelets also decrease in number, leading to thrombocytopenia.
Objectives. (1) To see effects of malaria on hematological profile; (2) To see the difference of changes due to malaria on hematological profile in both males and females.
Methodology. The study was conducted at Medical Department of Chandka Medical College, Larkana, on patients with malaria over a period of four months. The sample size was determined using the WHO calculator, and 87 patients were recruited who were diagnosed with malaria through rapid acting ICT method. Patients with recent full blood count reports were included, while those under 13 years of age or with co-morbidities were excluded. Ethical approval was obtained, and data was collected through a pre-tested questionnaire and analyzed using IBM SPSS version 22 software.
Results. The study found that malaria caused hematological changes in patients. Hemoglobin levels were affected in 72.4% of patients, with 27.6% showing mild anemia, 34.5% moderate anemia, and 10.3% severe anemia. Females were more affected than males. Platelet counts decreased in 44.8% of patients, with 13.8% experiencing mild thrombocytopenia, 16.1% moderate, and 14.9% severe thrombocytopenia, while a small proportion had thrombocytosis. Females were again more affected. Granulocytes were not affected by malaria.
References
Stanford health care. (2019). Stanfordhealthcare.org. https://stanfordhealthcare.org/medical-conditions/primary-care/malaria/types.html
CDC-Centers for Disease Control, & Prevention. (2009). CDC - Malaria - About Malaria - Biology. https://www.cdc.gov/malaria/about/biology/index.html
Zekar, L., & Sharman, T. (2022). Plasmodium Falciparum Malaria. StatPearls Publishing.
P. vivax malaria symptoms & severity. (n.d.). PVIVAX. Retrieved March 18, 2023, from https://www.vivaxmalaria.org/p-vivax-malaria-an-introduction/p-vivax-malaria-symptoms-severity?gclid=EAIaIQobChMIkqfqnLHi_QIVqggGAB2buAaaEAAYASAAEgJ66_D_BwE
Bartoloni, A., & Zammarchi, L. (2012). Clinical aspects of uncomplicated and severe malaria. Mediterranean Journal of Hematology and Infectious Diseases, 4(1), e2012026. https://doi.org/10.4084/MJHID.2012.026
Nucleic acid amplification-based diagnostics. (n.d.). Who.int. Retrieved March 18, 2023, from https://www.who.int/teams/global-malaria-programme/case-management/diagnosis/nucleic-acid-amplification-based-diagnostics
Adamu, J., & Jigam, A. A. (2019). Effects of malaria infection on some haematological and biochemical parameters in the general population and pregnant malaria patients attending two district hospitals in Niger State, Nigeria. Global Journal of Infectious Diseases and Clinical Research, 5(1), 001–005. https://doi.org/10.17352/2455-5363.000021
Awoke, N., & Arota, A. (2019). Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia. Infection and Drug Resistance, 12, 521–527. https://doi.org/10.2147/IDR.S184489
Malaria and Hematological changes. (n.d.). Com.Pk. Retrieved March 18, 2023, from https://pjms.com.pk/issues/aprjun108/article/article20.html
Thrombocytopenia. (n.d.). Cleveland Clinic. Retrieved March 18, 2023, from https://my.clevelandclinic.org/health/diseases/14430-thrombocytopenia
Malaria. (2023, February 9). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/malaria/symptoms-causes/syc-20351184
Paho. (n.d.). Paho.org. Retrieved March 18, 2023, from https://www3.paho.org/hq/index.php?option=com_content&view=article&id=2573:2010-general-information-malaria&Itemid=2060&lang=fr#gsc.tab=0
Microscopy. (n.d.). Who.int. Retrieved March 18, 2023, from https://www.who.int/teams/global-malaria-programme/case-management/diagnosis/microscopy
Rapid diagnostic tests. (n.d.). Who.int. Retrieved March 18, 2023, from https://www.who.int/teams/global-malaria-programme/case-management/diagnosis/rapid-diagnostic-tests
Empendium (n.d.). Empendium.com. Retrieved March 18, 2023, from https://empendium.com/mcmtextbook-sae/chapter/B78.II.15.1.?rfmcm
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Terms and conditions of Creative Commons Attribution 4.0 International License apply to all published manuscripts. This Journal is licensed under a Creative Commons Attribution 4.0 International License. This licence allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs and other platforms by providing appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
A competing interest exists when professional judgment concerning the validity of research is influenced by a secondary interest, such as financial gain. We require that our authors reveal all possible conflicts of interest in their submitted manuscripts.
The Editor reserves the right to shorten and adjust texts. Significant changes in the text will be agreed with the Authors.
ISSN 
